Affordable Access

Access to the full text

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

Authors
  • Bald, Tobias1
  • Krummel, Matthew F.2
  • Smyth, Mark J.1
  • Barry, Kevin C.3
  • 1 QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia , Herston (Australia)
  • 2 and Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA , San Francisco (United States)
  • 3 Fred Hutchinson Cancer Research Center, Seattle, WA, USA , Seattle (United States)
Type
Published Article
Journal
Nature Immunology
Publisher
Springer Nature
Publication Date
Jul 20, 2020
Volume
21
Issue
8
Pages
835–847
Identifiers
DOI: 10.1038/s41590-020-0728-z
Source
Springer Nature
License
Yellow

Abstract

In this Review, Smyth and colleagues provide an overview of recent advances in NK cell biology and discuss the progress and problems of NK cell–based cancer immunotherapies.

Report this publication

Statistics

Seen <100 times